METAVIA INC. (MTVA) Announces Clinical Trial Update
METAVIA INC. (MTVA) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: timeline
Diseases/Conditions: topline data release dates
Clinical Stage: clinical trial
Targeting MASH at Its Source Harrison et al., Clinical Gastroenterology and Hepatology, 2023
Targeting Obesity and MASH with a Pipeline of Next Generation Therapeutics • DA-1726
📋 METAVIA INC. (MTVA) - Clinical Trial Update
Filing Date: 2026-03-26
Accepted: 2026-03-26 16:30:11
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: